Furthermore, SESN2 may inhibit the production of ROS and produce antioxidant effects, making it a potential target for the treatment of AD and neurodegenerative diseases, as AD neuronal death is likely caused by oxidative damage (Wang et al., 2019). The gene discussed is SESN2; the disease is Alzheimer disease.